Comparison between Indo US Bio-Tech IPO and Narmada Agrobase IPO.
Indo US Bio-Tech IPO is a SME Fixed Price IPO proposed to list at BSE SME while Narmada Agrobase IPO is a SME Fixed Price proposed to list at NSE SME.
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Corporate Capital Ventures Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Beeline Broking Ltd. | Beeline Broking Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Indo US Bio-Tech IPO is up to ₹6.92 Cr whereas the issue size of the Narmada Agrobase IPO is up to ₹7.09 Cr. The final issue price of Indo US Bio-Tech IPO is ₹51.00 per share and of Narmada Agrobase IPO is ₹32.00 per share.
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹32.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 13,56,000 shares | 22,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.92 Cr | up to ₹7.09 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,56,000 shares | 22,16,000 shares |
| Issue Size Total (Amount) | up to ₹6.92 Cr | up to ₹7.09 Cr |
Indo US Bio-Tech IPO opens on Apr 30, 2018, while Narmada Agrobase IPO opens on Mar 28, 2018. The closing date of Indo US Bio-Tech IPO and Narmada Agrobase IPO is May 03, 2018, and Apr 11, 2018, respectively.
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 30, 2018 | Mar 28, 2018 |
| Issue Close | May 03, 2018 | Apr 11, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 11, 2018 | Apr 19, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indo US Bio-Tech IPO P/E ratio is , as compared to Narmada Agrobase IPO P/E ratio of .
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹24.76 Cr. | ₹24.09 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Indo US Bio-Tech IPO Retail Individual Investors (RII) are offered 6,78,000 shares while in Narmada Agrobase IPO retail investors are offered 6,78,000 shares. Qualified Institutional Buyers (QIB) are offered in Indo US Bio-Tech IPO and in Narmada Agrobase IPO.
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 74,000 shares | 1,24,000 shares |
| QIB | ||
| NII | 6,78,000 shares | 11,08,000 shares |
| RII | 6,78,000 shares | 11,08,000 shares |
| Employee | ||
| Others | ||
| Total | 13,56,000 shares | 22,16,000 shares |
Indo US Bio-Tech IPO subscribed 19.69x in total, whereas Narmada Agrobase IPO subscribed 1.21x.
| Indo US Bio-Tech IPO | Narmada Agrobase IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 19.52x | 0.93x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.87x | 1.48x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 19.69x | 1.21x |
